EFFICACY OF A SPECIFIC INHIBITOR  (STI571)
OF THE BCR-ABL TYROSINE KINASE IN
CHRONIC MYELOID LEUKEMIA
Immunoblot assays demonstrating the degree of phosphorylation of the
BCR-ABL substrate CRKL in individual patients in the group receiving
increasing dose of STI 571
From: Drucker et al, 2001 N. Engl. J. Med. 344 1031-1037
2003-2004